Soleno Therapeutics, Inc.

BST:6XC1 Stock Report

Market Cap: €23.0m

Soleno Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:6XC1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Jan 25Sell€134,770Patricia HiranoIndividual3,030€44.86
03 Jan 25Sell€216,165Kristen YenIndividual4,860€44.86
03 Jan 25Sell€938,095Anish BhatnagarIndividual21,091€44.86
03 Jan 25Sell€350,223James MacKanessIndividual7,874€44.86
19 Nov 24Sell€39,478,489Perceptive Advisors LLCCompany813,208€54.03
23 Oct 24Sell€30,472,230Perceptive Advisors LLCCompany647,471€50.58
17 Oct 24Sell€24,934,966Abingworth LLPCompany499,047€50.38
08 Oct 24Sell€41,489,686Abingworth LLPCompany849,897€48.93
01 Oct 24Sell€966,011Anish BhatnagarIndividual21,633€45.39
01 Oct 24Sell€138,786Patricia HiranoIndividual3,108€45.39
01 Oct 24Sell€360,675James MacKanessIndividual8,077€45.39
01 Oct 24Sell€138,786Kristen YenIndividual3,108€45.39
29 Aug 24Sell€44,427,465Vivo Capital, LLCCompany1,025,000€43.99
29 Aug 24Sell€4,924,510Anish BhatnagarIndividual115,004€43.36
29 Aug 24Sell€458,392Patricia HiranoIndividual10,705€43.36
29 Aug 24Sell€579,401James MacKanessIndividual13,531€43.36
29 Aug 24Sell€458,392Kristen YenIndividual10,705€43.36
06 Aug 24Sell€5,311,385Anish BhatnagarIndividual127,344€42.21
06 Aug 24Sell€459,174Patricia HiranoIndividual11,009€42.21
06 Aug 24Sell€624,925James MacKanessIndividual14,983€42.21
06 Aug 24Sell€457,714Kristen YenIndividual10,974€42.21
01 Jul 24Sell€745,934Anish BhatnagarIndividual19,256€38.82
01 Jul 24Sell€278,524James MacKanessIndividual7,190€38.82
01 Jul 24Sell€84,061Patricia HiranoIndividual2,170€38.82
01 Jul 24Sell€84,061Kristen YenIndividual2,170€38.82
30 Apr 24Sell€48,351,291Vivo Capital, LLCCompany1,101,242€44.70
01 Apr 24Sell€85,367Kristen YenIndividual2,218€38.79
01 Apr 24Sell€85,367Patricia HiranoIndividual2,218€38.79
01 Apr 24Sell€730,504Anish BhatnagarIndividual18,980€38.79
01 Apr 24Sell€199,176James MacKanessIndividual5,175€38.79
25 Jan 24Sell€37,079Patricia HiranoIndividual832€44.57
25 Jan 24Sell€112,619Anish BhatnagarIndividual2,527€44.57
25 Jan 24Sell€17,693Kristen YenIndividual397€44.57

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6XC1?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds9,436,5127.77%
Individual Insiders13,044,20510.7%
Institutions21,469,65717.7%
VC/PE Firms24,383,95120.1%
General Public53,184,49143.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 52.4%.

Top Shareholders

Top 25 shareholders own 55.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
Abingworth LLP
18,022,602€3.4m0%1.04%
7.99%
Jack Schuler
9,707,848€1.8m0%no data
7.77%
Nantahala Capital Management, LLC
9,436,512€1.8m0%0.13%
6.51%
Schuler Family Foundation, Endowment Arm
7,911,804€1.5m0%93.96%
5.23%
Aigh Capital Management, LLC
6,361,349€1.2m-6.45%0.45%
3.03%
Birchview Capital, LP
3,676,899€695.6k0%0.48%
2.2%
Ernest Mario
2,674,418€505.9k-18.8%no data
2.18%
Granite Point Capital Management, L.P.
2,646,850€500.7k0%0.41%
1.75%
Oracle Investment Management, Inc.
2,132,000€403.3k0%0.09%
1.68%
The Vanguard Group, Inc.
2,035,806€385.1k-0.78%no data
0.45%
Renaissance Technologies LLC
550,131€104.1k122%no data
0.4%
Geode Capital Management, LLC
488,393€92.4k13.5%no data
0.21%
Boothbay Fund Management, LLC
252,154€47.7k0%no data
0.2%
Two Sigma Advisers, LP
246,400€46.6k0%no data
0.2%
Anish Bhatnagar
239,727€45.4k0%no data
0.19%
State Street Global Advisors, Inc.
231,741€43.8k0%no data
0.17%
Two Sigma Investments, LP
208,546€39.5k0%no data
0.12%
Citadel Advisors LLC
144,623€27.4k0%no data
0.12%
BNP Paribas Arbitrage Sa, Asset Management Arm
140,018€26.5k0%no data
0.11%
William Harris
133,518€25.3k0%no data
0.087%
Birgitte Volck
105,678€20.0k0%no data
0.087%
Northern Trust Global Investments
105,481€20.0k0%no data
0.082%
Wilcoxson Wealth Management
100,000€18.9k0%no data
0.081%
Oppenheimer Asset Management Inc.
98,054€18.5k-57.8%no data
0.074%
Warberg Asset Management
90,000€17.0k233%0.08%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/08/16 21:35
End of Day Share Price 2022/05/19 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Soleno Therapeutics, Inc. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Kristen KluskaCantor Fitzgerald & Co.
François BriseboisCraig-Hallum Capital Group LLC